Caption Management, LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 320 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
Caption Management, LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,721,600
-64.9%
60,000
-68.3%
0.04%
-69.6%
Q2 2023$7,754,670
+26.7%
189,000
+10.4%
0.14%
+16.9%
Q1 2023$6,118,688
+89.5%
171,200
+100.2%
0.12%
+131.4%
Q4 2022$3,229,335
-33.6%
85,500
-22.3%
0.05%
-23.9%
Q3 2022$4,866,000
-34.3%
110,000
-45.0%
0.07%
-34.3%
Q2 2022$7,404,000
+91.6%
200,000
+57.5%
0.10%
+131.8%
Q4 2021$3,864,000
-51.2%
127,000
-46.2%
0.04%
-51.1%
Q3 2021$7,916,000
-46.3%
235,993
-36.1%
0.09%
-53.1%
Q2 2021$14,732,000
+446.0%
369,307
+515.5%
0.19%
+231.0%
Q1 2021$2,698,000
-82.1%
60,000
-77.5%
0.06%
-83.1%
Q4 2020$15,108,000
+39.6%
267,227
+17.2%
0.34%
+36.0%
Q3 2020$10,819,000
-29.0%
228,000
-11.7%
0.25%
-50.1%
Q2 2020$15,228,000
+162.4%
258,276
+186.0%
0.51%
+73.6%
Q2 2019$5,804,000
-31.9%
90,300
-14.0%
0.29%
-37.9%
Q1 2019$8,523,000105,0000.47%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders